| Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients (NCT05670054) | Mansoura University | 2022-03-01 |
| Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. (NCT04896320) | Providence Health & Services | 2021-12-15 |
| A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer (NCT05190770) | Memorial Sloan Kettering Cancer Center | 2021-12-15 |
| Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients (NCT05033925) | Gadjah Mada University | 2021-10-25 |
| Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer (NCT05090358) | Memorial Sloan Kettering Cancer Center | 2021-10-08 |
| Sitravatinib in Metastatic Breast Cancer (NCT04123704) | Xiang Zhang | 2021-09-22 |
| A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer (NCT05054374) | Memorial Sloan Kettering Cancer Center | 2021-09-14 |
| BRaziLian outcomE for metAStatic breasT Cancer (NCT05559528) | Hospital do Coracao | 2021-09-13 |
| Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity (NCT05036252) | Memorial Sloan Kettering Cancer Center | 2021-08-27 |
| Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells (NCT04628806) | Charite University, Berlin, Germany | 2021-02-17 |
| SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells (NCT04150042) | General Oncology, Inc. | 2021-01-13 |
| Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. (NCT04852081) | Blokhin's Russian Cancer Research Center | 2021-01-01 |
| The Benefit of Surgery in Stage IV of Breast Cancer (NCT04697043) | Tehran University of Medical Sciences | 2020-11-20 |
| Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases (NCT04752059) | Medical University of Vienna | 2020-07-28 |
| Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients (NCT03870919) | UNICANCER | 2019-10-23 |
| Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy (NCT04133207) | Hellenic Cooperative Oncology Group | 2019-01-01 |
| Self-Advocacy Serious Game in Advanced Cancer (NCT03339765) | University of Pittsburgh | 2018-12-13 |
| A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer (NCT03045289) | University of Rochester | 2018-07-05 |
| The Resistance and Immune Response to Palbociclib in Breast Cancer (NCT03401359) | Samsung Medical Center | 2017-10-24 |
| Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients (NCT03032614) | The University of Texas Health Science Center at San Antonio | 2017-09-30 |
| PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer (NCT03304210) | University Hospital, Ghent | 2017-09-16 |
| To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors (NCT03159585) | Zhujiang Hospital | 2017-04-14 |
| A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer (NCT02448771) | Dana-Farber Cancer Institute | 2015-07-09 |
| Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer (NCT00393341) | Indiana University | 2006-10-01 |